Recommendations for the clinical use of cyclooxygenase-2–specific inhibitors
- 1 February 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 110 (3) , 3-5
- https://doi.org/10.1016/s0002-9343(00)00680-x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain modelClinical Pharmacology & Therapeutics, 1999
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsArthritis & Rheumatism, 1998
- Biologic effects of nonsteroidal anti-inflammatory drugsCurrent Opinion in Rheumatology, 1997
- Gastrointestinal Tract Complications of Nonsteroidal Anti-inflammatory Drug Treatment in Rheumatoid ArthritisArchives of internal medicine (1960), 1996
- The Mechanisms of Action of NSAIDs in AnalgesiaDrugs, 1996